Gaxos.ai Secures Preferred Pricing and Early Access to ByteDance Video Models in New BytePlus Deal

GXAI
February 17, 2026

Gaxos.ai announced a partnership with BytePlus, the enterprise technology division of ByteDance, that grants the company preferred pricing and early access to ByteDance’s cutting‑edge video generation models for its flagship Art‑Gen platform.

Under the agreement, BytePlus will provide Gaxos with early releases of new models and discounted pricing, which is expected to lower infrastructure costs and improve scalability for Art‑Gen. The partnership will allow Gaxos to embed these advanced models into its platform, enhancing the creative capabilities available to creators worldwide.

The deal is part of Gaxos’s broader strategy to diversify its AI offerings across entertainment and health sectors. By securing cost advantages and early access to advanced models, Gaxos aims to strengthen its competitive position in the multi‑billion‑dollar creator economy and drive higher margins as subscription and credit‑based tiers for Art‑Gen expand. The company has faced stagnant revenue and significant losses in recent years, so the partnership could provide a much‑needed boost to its economics.

CEO Vadim Mats said, “We are thrilled to deepen our relationship with BytePlus and leverage ByteDance’s world‑class AI video technology. This partnership enhances our ability to deliver unparalleled creative power to users worldwide while driving stronger economics for our business. It is a significant step toward making Gaxos the go‑to AI platform for both creators and enterprises.”

The announcement was well received by investors, reflecting confidence in the partnership’s potential to strengthen Gaxos’s competitive position and improve its financial outlook.

The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.